| Extended-spectrum β-lactamases: a clinical update DL Paterson, RA Bonomo Clinical microbiology reviews 18 (4), 657-686, 2005 | 5470 | 2005 |
| Three decades of β-lactamase inhibitors SM Drawz, RA Bonomo Clinical microbiology reviews 23 (1), 160-201, 2010 | 2238 | 2010 |
| Global Challenge of Multidrug-Resistant Acinetobacter baumannii F Perez, AM Hujer, KM Hujer, BK Decker, PN Rather, RA Bonomo Antimicrobial agents and chemotherapy 51 (10), 3471-3484, 2007 | 1855 | 2007 |
| Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases LS Munoz-Price, L Poirel, RA Bonomo, MJ Schwaber, GL Daikos, ... The Lancet infectious diseases 13 (9), 785-796, 2013 | 1844 | 2013 |
| Carbapenems: past, present, and future KM Papp-Wallace, A Endimiani, MA Taracila, RA Bonomo Antimicrobial agents and chemotherapy 55 (11), 4943-4960, 2011 | 1782 | 2011 |
| Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa RA Bonomo, D Szabo Clinical infectious diseases 43 (Supplement_2), S49-S56, 2006 | 1128 | 2006 |
| Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges D Wong, TB Nielsen, RA Bonomo, P Pantapalangkoor, B Luna, ... Clinical microbiology reviews 30 (1), 409-447, 2017 | 1017 | 2017 |
| 10×'20 progress—development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America HW Boucher, GH Talbot, DK Benjamin Jr, J Bradley, RJ Guidos, ... Clinical infectious diseases 56 (12), 1685-1694, 2013 | 878 | 2013 |
| Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical … DL Paterson, WC Ko, A Von Gottberg, JM Casellas, L Mulazimoglu, ... Journal of clinical microbiology 39 (6), 2206-2212, 2001 | 861 | 2001 |
| International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections DL Paterson, WC Ko, AV Gottberg, S Mohapatra, JM Casellas, ... Annals of internal medicine 140 (1), 26-32, 2004 | 835 | 2004 |
| Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients CJ Donskey, TK Chowdhry, MT Hecker, CK Hoyen, JA Hanrahan, ... New England Journal of Medicine 343 (26), 1925-1932, 2000 | 802 | 2000 |
| Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases DL Paterson, WC Ko, A Von Gottberg, S Mohapatra, JM Casellas, ... Clinical infectious diseases 39 (1), 31-37, 2004 | 801 | 2004 |
| Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army … KM Hujer, AM Hujer, EA Hulten, S Bajaksouzian, JM Adams, CJ Donskey, ... Antimicrobial agents and chemotherapy 50 (12), 4114-4123, 2006 | 686 | 2006 |
| Better tests, better care: improved diagnostics for infectious diseases AM Caliendo, DN Gilbert, CC Ginocchio, KE Hanson, L May, TC Quinn, ... Clinical Infectious Diseases 57 (suppl_3), S139-S170, 2013 | 661 | 2013 |
| Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and … DL Paterson, KM Hujer, AM Hujer, B Yeiser, MD Bonomo, LB Rice, ... Antimicrobial agents and chemotherapy 47 (11), 3554-3560, 2003 | 598 | 2003 |
| Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clinical Infectious Diseases 66 (2), 163-171, 2018 | 576 | 2018 |
| Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System MD Adams, GC Nickel, S Bajaksouzian, H Lavender, AR Murthy, ... Antimicrobial agents and chemotherapy 53 (9), 3628-3634, 2009 | 565 | 2009 |
| Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii MD Adams, K Goglin, N Molyneaux, KM Hujer, H Lavender, JJ Jamison, ... Journal of bacteriology 190 (24), 8053-8064, 2008 | 552 | 2008 |
| Ceftazidime/avibactam and ceftolozane/tazobactam: second-generation β-lactam/β-lactamase inhibitor combinations D van Duin, RA Bonomo Clinical Infectious Diseases 63 (2), 234-241, 2016 | 537 | 2016 |
| “Stormy waters ahead”: global emergence of carbapenemases G Patel, RA Bonomo Frontiers in microbiology 4, 48, 2013 | 528 | 2013 |
